CI INVESTMENTS INC. - TG THERAPEUTICS INC ownership

TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 234 filers reported holding TG THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 1.18 and the average weighting 0.1%.

Quarter-by-quarter ownership
CI INVESTMENTS INC. ownership history of TG THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$18
-67.3%
2,136
-2.9%
0.00%
Q2 2023$55
-59.3%
2,200
-75.5%
0.00%
-100.0%
Q1 2023$135
+25.0%
8,994
-1.3%
0.00%0.0%
Q4 2022$108
-99.2%
9,110
+287.7%
0.00%
Q3 2022$14,000
+27.3%
2,350
-6.9%
0.00%
Q2 2022$11,000
+10.0%
2,525
+147.1%
0.00%
Q1 2022$10,0001,022
+14500.0%
0.00%
Q3 2021$070.00%
Other shareholders
TG THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
M28 Capital Management LP 726,200$3,086,0003.46%
Paradigm Biocapital Advisors LP 1,964,709$8,350,0001.66%
683 Capital Management, LLC 3,300,000$14,025,0000.99%
MAVERICK CAPITAL LTD 6,747,549$28,677,0000.71%
Antara Capital LP 1,500,000$6,375,0000.27%
Parkwood LLC 47,168$1,375,0000.24%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 2,677,500$11,379,0000.24%
PURA VIDA INVESTMENTS, LLC 950,813$4,041,0000.24%
OCCUDO QUANTITATIVE STRATEGIES LP 567,576$2,412,0000.20%
Antara Capital LP 900,000$3,825,0000.16%
View complete list of TG THERAPEUTICS INC shareholders